Co-Diagnostics Joins UNOPS Workshop on TB Diagnostics in Bangkok — Co-Diagnostics, Inc. (Co-Dx)

Event summary

Co-Diagnostics invited as manufacturer partner for UNOPS Global Implementation Workshop on Near Point of Care (NPOC) TB Diagnostics in Bangkok, July 8-10, 2026.
Workshop includes delegates from 21 countries and over 50 organizations to discuss WHO-recommended NPOC diagnostics for tuberculosis.
Co-Dx PCR platform showcased as a potential solution for decentralized testing environments aligned with updated WHO guidelines.
Platform integrates sample preparation, amplification, and detection in a single workflow, targeting easy-to-collect tongue swabs.

The big picture

The invitation to the UNOPS workshop positions Co-Diagnostics as a key player in advancing WHO-recommended TB diagnostics. The event underscores the growing emphasis on decentralized, near-point-of-care testing solutions, aligning with global health initiatives to combat tuberculosis. Success here could open doors to significant funding opportunities through the Global Fund and other international health organizations.

What we're watching

Regulatory Approval: The pace at which the Co-Dx PCR platform secures FDA and other regulatory approvals will determine its market readiness.
Market Adoption: Whether the platform's integration capabilities can drive widespread adoption in decentralized testing environments.
Competitive Positioning: How Co-Diagnostics differentiates itself against existing and emerging NPOC diagnostic solutions.